# Performance Evaluation of Malaria Plus RDTs

> **NCT03960632** · — · UNKNOWN · sponsor: **Foundation for Innovative New Diagnostics, Switzerland** · enrollment: 6546 (estimated)

## Conditions studied

- Malaria

## Interventions

- **DIAGNOSTIC_TEST:** Abbott SD Bioline Malaria Pf Plus (05FK150) and Abbott SD Bioline Malaria Pf/Pv Plus (05FK160))

## Key facts

- **NCT ID:** NCT03960632
- **Lead sponsor:** Foundation for Innovative New Diagnostics, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06
- **Primary completion:** 2021-09
- **Final completion:** 2021-09
- **Target enrollment:** 6546 (ESTIMATED)
- **Last updated:** 2020-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03960632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03960632, "Performance Evaluation of Malaria Plus RDTs". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03960632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*